Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Takeda
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb
Case Comprehensive Cancer Center
Eastern Cooperative Oncology Group
Children's Oncology Group
Medical College of Wisconsin
Seagen Inc.
Children's Oncology Group
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Children's Oncology Group
Vanderbilt-Ingram Cancer Center
Alliance for Clinical Trials in Oncology
Novartis
University of Cologne
INSYS Therapeutics Inc
St. Jude Children's Research Hospital
Vanderbilt-Ingram Cancer Center
Mayo Clinic